Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180530 | SCV000232992 | benign | not specified | 2015-06-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000967664 | SCV001115066 | likely benign | Cholestanol storage disease | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001546144 | SCV001765612 | likely benign | not provided | 2021-06-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390444 | SCV002702401 | benign | Cardiovascular phenotype | 2021-05-10 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001546144 | SCV004151406 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | CYP27A1: BP4, BS2 |
Prevention |
RCV003937640 | SCV004748537 | likely benign | CYP27A1-related disorder | 2019-06-19 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV001546144 | SCV001921639 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001546144 | SCV001975665 | likely benign | not provided | no assertion criteria provided | clinical testing |